// App-Quantinova.ai

ABS018 : ROTEM ASSAY CONDITIONS SENSITIVE TO CONCIZUMAB

Researchers

Presenter

  • C. Augustsson

Principal Investigators

  • A. Riddell

  • I. Fernandez-Bello

  • N. Butta

  • M. Kjalke

  • J. Astermark

  • H. Eichler

  • V. Jimenez Yuste

  • P. Chowdary

Medical Centers

  • Clinical Chemistry and Pharmacology, Malmoe, Sweden

  • KD Haemophilia and Thrombosis Centre, Royal Free Hospital, London, United Kingdom

  • Haematology, La Paz University Hospital-IdiPaz, Madrid, Spain

  • Novo NordiskA/S, Soborg, Denmark

  • Centre for Thrombosis and Haemostasis, Skåne University Hospital, Lund University, Malmö, Sweden

  • Institute of Clinical Hemostaseology and Transfusion Medicine, Saarland University and University Hospital, Homburg/Saar, Germany

Locations

  • Sweden

  • United Kingdom

  • Spain

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

  • NN7415

  • rFVIIa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved